Evidera on Thursday, May 30, announced the acquisition of Medimix International, a global tech company that uses real-world evidence to generate insights into the pharmaceutical, diagnostic and medical device industries.
According to a press release, the arrangement will allow Evidera to bolster its “technology solutions, real-world data and access to health care providers.”
“The addition of Medimix will expand our ability to help our clients plan for and generate the evidence needed to optimize the market access and commercial potential of their products,” Evidera President Karen Kaucic said in a statement. “We look forward to leveraging the capabilities and resources of Medimix to develop novel approaches to access and maximize the utility of real-world data.”
Evidera and Medimix have sent representatives to the American Society of Clinical Oncology’s meeting in Chicago (May 31-June 4), and will be on hand to offer further details at booth #22107.
To learn more about Evidera, click here.